Ahmad Almaya, PhD

Eli Lilly & Co
Director
Dr. Ahmad Almaya is currently a Director in the Small Molecule Design and Development organization within Lilly R&D. He holds a bachelor degree in Pharmacy, a Ph.D. degree in Pharmaceutics, and an Executive Certificate in the Business of Life Sciences. He joined Lilly in 2002 where he led formulation and process development teams for the development of a wide range of dosage forms and manufacturing platforms. Ahmad served as the scientific team leader for the investigation and optimization of continuous direct compression technology within Lilly’s R&D organization during the period 2012-2014. Since then he has led multiple development teams and partnered with Lilly Manufacturing on implementing continuous manufacturing for several Lilly portfolio molecules.

Related Articles

Regulatory Aspects of Global Acceptance of Continuous Manufacturing
Features
Regulatory Aspects of Global Acceptance of Continuous Manufacturing

Application of continuous manufacturing (CM) in the pharmaceutical industry is gaining momentum. Most of the current experience is based on oral solid dosage (OSD) projects but in the future continuous manufacturing should not be limited to these dosage forms. In this article, the regulatory acceptability of continuous manufacturing to produce pharmaceuticals is demonstrated in different...